Carotid angioplasty and stenting under protection: Advantages and drawbacks

Expert Review of Medical Devices

Volumn 5, Issue 5, 2008, Pages 591-603

  Henry, Michel ^a,b   Polydorou, Antonio ^c   Henry, Isabelle ^d   Hugel, Michéle ^a,b  

^a Cabinet de Cardiologie   (France)

^b Global Research Institute   (India)

^c IASO GENERAL HOSPITAL   (Greece)

^d Polyclinique Bois Bernard ^*  (France)

Author keywords

Carotid angioplasty; Protection device; Stenting; Stroke

Indexed keywords

SPASMOLYTIC AGENT;

ANGIOPLASTY; ARTERY DISSECTION; ARTERY SPASM; BALLOON CATHETER; BALLOON DILATATION; BALLOON OCCLUSION; BRAIN BLOOD FLOW; BRAIN EMBOLISM; BRAIN PROTECTION; CAROTID ANGIOPLASTY; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COLLATERAL CIRCULATION; ENDARTERECTOMY; FILTER; HIGH RISK PATIENT; HUMAN; IN-STENT RESTENOSIS; NEUROLOGICAL COMPLICATION; REVASCULARIZATION; REVIEW; RISK REDUCTION; STENT; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT OUTCOME; ARTIFICIAL EMBOLISM; INSTRUMENTATION;

ANGIOPLASTY; CAROTID STENOSIS; EMBOLIZATION, THERAPEUTIC; HUMANS; STENTS; TREATMENT OUTCOME;

EID: 55249091345     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.5.5.591     Document Type: Review

References (94)

1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of the carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N. Engl. J. Med. 325, 445-453 (1991).
2. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-90%) or with mild (0-29%) carotid stenosis. Lancet 337, 1235-1243 (1991).
3. Mayberg MR, Wilson SE, Yatsu F et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialists Group. JAMA 266, 3289-3294 (1991).
4. Executive Committee for the asymptomatic carotid atherosclerotic study: endarterectomy for asymptomatic carotid artery stenosis. JAMA 273, 1421-1428 (1995).
5. MRC Asymptomatic Carotid Surgery Trial (ACST) Colhiborative Group Prevention. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet 363, 1491-1502 (2004).
6. Rothwell PM, Slatterg J, Waslow CP et al. A systematic review of the risks of stroke or death due to endarterectomy for symptomatic carotid stenosis. Stroke 27, 260-265 (1996).
7. Ouriel K, Hertzer NR, Beven EG et al. Preprocedural risks stratification: identifying an appropriate population for carotid stenting. J. Vasc. Surg. 33, 728-732 (2001).
8. Yadav JS, Roubin GS, Iyer S et al. Elective stenting of the extracranial carotid arteries. Circulation 95, 376-381 (1997).
9. Diethrich EB, Ndiaye M, Reid DB et al. Stenting in the carotid artery: initial experience in 110 patients. J. Endovasc. Surg. 3, 42-46 (1996).
10. Roubin GS, Yadav S, Iyer S et al. Carotid stent-supported angioplasty: a neurovascular intervention to prevent stroke. Am. J. Cardiol. 78 (Suppl. 3A), 8-12 (1996).
11. Henry M, Amor M, Masson I et al. Angioplasty and stenting of the extracranial carotid arteries. J. Endovasc. Surg. 5, 293-304 (1998).
12. Henry M, Amor M, Klonaris C et al. Angioplasty and stenting of the extracranial carotid arteries. Tex. Heart Inst. J. 27, 150-158 (2000).
13. Shawl F, Kadro W, Domanski MJ et al. Safety and efficacy of elective carotid artery stenting in high-risk patients. J. Am. Coll. Cardiol. 35, 1721-1728 (2000).
14. Henry M, Amor M, Masson I et al. Endovascular treatment of atherosclerotic stenosis of the internal carotid artery. J. Cardiovascular Surg. 39(Suppl. 1), 141-150 (1998).
15. Roubin GS, New G, Iyer S et al. Immediate and late clinical outcome of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis. Circulation 103, 532-537 (2001).
16. Wholey MH, Wholey MH, Tan WA et al. Management of neurological complication of carotid artery stenting. J. Endovasc. Ther. 8, 341-353 (2001).
17. Cremonesi A, Castriota F, Manetti R et al. Endovascular treatment of carotid atherosclerotic disease: early and late outcome in a non selected population. Ital. Heart J. 1, 801-809 (2000).
18. Gupca A, Bhatia A, Shalev Y et al. Carotid Scenting in patients older than 65 years with ingerable carotid artery disease: a single center experience. Catheter. Cardiovasc. Interv. 50, 1-8 (2000).
19. CAVATAS investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the carotid and vertebral artery transluminal angioplasty study (CAVATAS: a randomized trial). Lancet 357, 1729-1737 (2001).
20. Brooks WH, Mc Lure RR, Jones MR et al. Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J. Am. Coll. Cardiol. 38, 1589-1595 (2001).
21. Vitek JJ, Raymon BC, Oh SJ et al. Innominate artery angioplasty. Am. J. Neuroradiol. 5, 113-114 (1984).
22. Theron J, Raymond J, Casasco A et al. Percutaneous angioplasty of atherosclerotic and post-surgical stenosis of carotid arteries. Am. J. Neuroradiol. 8, 495-500 (1987).
23. Henry M, Amor M, Henry I et al. Carotid stenting with cerebral protection: first clinical experience using the Percussurge Guardwire System. J. Endovasc. Surg. 6, 321-331 (1999).
24. Henry M, Henry I, Klonaris C et al. Benefits of cerebral protection during carotid stenting with the Percussurge Guardwire System: mid-term results. J. Endovasc. Ther. 9, 1-13 (2002).
25. Parodi JC, Lamura R, Ferreira LM et al. Inintial evaluation of carotid angioplasty and stenting with three different cerebral protection devices. J. Vasc. Surg. 32, 1127-1136 (2000).
26. Reimers B, Corvoja N, Moshiris et al. Cerebral protection with filter devices during carotid arrtery stencing. Circulation 104, 12-15 (2001).
27. Wholey MH, AI Mubarak N, Wholey MH. Updated review of the global carotid artery stent registry. Catheter. Cardiovasc. Interv. 60, 259-266 (2003).
28. Cremonesi A, Metti R, Setacci F et al. Protectid carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke 34, 1936-1941 (2003).
29. Reimers B, Schlueter M, Castriota F. Routine use of cerebral protection during carotid artery stenting: results of a multicenter registry of 753 patients. Am. J. Med. 116, 217-222 (2004).
30. Kastrup A, Groschel K, Frapf H et al. Early outcome of carotid and stenting with and without protection devices: a systemic review of the literature. Stroke 34(3), 813-819 (2003).
31. Yadav JS, Wholey MH, Kuntz RE et al. Protected carotid artery stenting versus endarterectomy in high risk patients. N. Engl. J. Med. 351, 1493-1501 (2004)
32. Henry M, Polydorou A, Henry I et al. Carotid angioplasty under protection with the Percussurge Guardwire device. In: Angioplasty and Stenting of the Carotid and Supra Aortic Trunks. Henry M, Ohki T (Eds). Taylor and Francis, London, UK 485-496 (2004).
33. Parodi J, Bates MC, Schonholz CJ. Parodi embolization system: description and first results. In: Angioplasty and Stenting of the Carotid and Supra Aortic Trunks. Henry M, Ohki T (Eds). Taylor and Francis, London, UK 485-496 (2004).
34. CARESS Steering Committee. Carotid revascularization using endartectomy or stenting systems (CARESS): Phase I clinical trial. J. Endovasc. Ther. 1021-1030 (2003).
35. Flash H, Ouhlous M, Hendricks J et al. Cerebral ischemia after carotid intervention. J. Endovasc. Ther. 11, 251-257 (2004).
36. Reimers B, Sievert H, Schuler GC et al. Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry. J. Endovasc. Ther. 12, 156-165 (2005).
37. Wholey MH. The ARCHER trial: prospective clinical trial for carotid stenting In high surgical risk patients, preliminary thirty-day result. Presented at: 52nd Annual Meeting of the American College of Cardiology. Chicago, IL, USA, 30 March 2003.
38. Whitlow PL. Security: multicenter registry in high-risk symptomatic and asymptomatic carotid disease with the Abort Xact stent and MedNova filter. Presented at: Transcatheter Cardiovascular Therapeutics (TCT). Washington, DC, USA, 15-19 September 2003.
39. Yadav J. Carotid stenting and endarterectomy for stroke prevention. Presented at: All That Jazz Meeting. New Orleans, LA, USA, May 2007.
40. White CJ, Iyer SS, Hopkins LN. Carotid scenting with distal protection in high surgical risk patients: the Beach Trial 30 day results. Catheter. Cardiovasc. Interv. 67, 503-512 (2006).
41. Hopkins N. CABERNET. 30-day pivotal results. Presented at: Transcatheter Cardiovascular Therapeutics (TCT). Washington, DC, USA, 27 September-1 October 2004.
42. Ramee S. MAVERIC II. A prospective registry of carotid stenting with the Exponent stent and distal protection with the Guardwire in high-risk patients: 30-days results. Presented at: Transcatheter Cardiovascular Therapeutics (TCT). Washington, DC, USA, 27 September-1 October 2004.
43. Gray W. A perspective on carotid stenting in 2007. Presented at: ISET Meeting. Miami, FL, USA, 28 January-1 February 2007.
44. Space collaborative group; Ringleb Pa, Allenberg J, Bruckmann H et al. 30-day results or the SPACE trial of stent protected angioplasty versus carotid endarterectomy in symptomatic patients. Lancet 368, 1239-1247 (2006).
45. Roubin G. Carotid angioplasty stenting. Presented at: AHA Meeting. Orlando, FL, USA, 9-12 November 2003.
46. Al-Mubarak N, Roubin GS, Vitek JJ et al. Effect of the distal-balloon protection system on microembolization during carotid Stenting. Circulation 104, 1999-2002 (2001).
47. Schmidt A, Dederich KW, Scheinert S et al. Effect of two different neuroprotection systems on microembolization during carotid artery stenting. J. Am. Coll. Cardiol. 44, 1966-1969 (2004).
48. Vos AJ, Vandenberg JC, Ernst SM et al. Carotid angioplasty and stent placement: comparison of transcranial Doppler VS data and clinical outcome with and without filtering cerebral protection devices in 509 patients. Radiology 234, 493-499 (2005).
49. Flach H, Ouhlous M, Hendriks J et al. Cerebral ischemia after carotid intervention. J. Endovasc. Ther. 11, 251-257 (2004).
50. Schlüter M, Tubler T, Steffens JC et al. Focal ischemia of the brain after neuroprotected carotid artery stenting. J. Am. Coll. Cardiol. 42, 1007-1013 (2003).
51. Roubin GS. Carotid angioplasty and stenting under cerebral protection: the standard of care. Presented at: International Congress XV. Scottsdale, AZ, USA, 11-14 February 2002.
52. Ohki T, Veith FJ. Carotid stenting with and without protection device: should protection be useful in all patients? Semin. Vasc. Surg. 13, 144-152 (2000).
53. Ohki T, Roubin GS, Veith FJ et al. Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting. An ex-vivo analysis. J. Vasc. Surg. 30, 1034-1044 (1999).
54. Henry M, Henry I, Klonaris C et al. Benefits of cerebral protection during carotid stenting with the Percusurge Guardwire system: mid-term results. J. Endovasc. Ther. 9, 1-13 (2002).
55. Theron J, Payelle G, Coskun O et al. Carotid artery stenosis: treatment with protected balloon angioplasty and stent placement. Radiology 201, 627-636 (1996).
56. Reimers B, Corvaja N, Moshiri S et al. Cerebral protection with filter devices during carotid artery stenting. Circulation 104, 12-15 (2001).
57. Parodi JC, Lamura R, Ferreira LM et al. initial evaluation of carotid angioplasty and stenting with three different cerebral protection devices. J. Vasc. Surg. 32, 1127-1136 (2000).
58. Arjomand H, Gordin P, Bruno N et al. Outcome of carotid artery stenting in high and low surgical risk patients. Am. J. Cardiol. 94, 62E (2004).
59. Parodi JC, Schonholtz C, Parodi FE et al. Initial 200 cases of carotid artery stenting using a reversal flow cerebral protection device. J. Cardiovasc. Surg. 48, 117-124 (2007).
60. Henry M, Amor M, Henry I et al. Carotid stenting with cerebral protection: first clinical experience using the percusurge guardwire system. J. Endovasc. Surg. 6, 321-331 (1999).
61. Mehran R, Roubin GS, New G et al. Neurologic events after carotid stenting with distal protection using an occlusion balloon: final results from the Café USA Trial. Presented at: AHA Meeting. Anaheim, CA, USA, 12 November 2001.
62. Cremonesi A. The spider embolic protection device performance evaluation in the carotid artery during percutaneous transluminal angioplasty and/ or stenting. J. Invasive Cardiol. 17, 463-467 (2005).
63. Castriota F, Cremonesi A, Manetti R et al. Carotid angioplasty and stenting with and without cerebral protection: single center experience in 275 consecutive patients. Presented at: International Congress XV Scottsdale, AZ, USA 11-14 February 2002.
64. Mac Donald S, Cleveland TJ, Evans D et al. A comparison of the high-intensity signal rate using transcranial Doppler during unprotected and protected carotid stenting (Neuroshield) with a randomized controlled trial. Presented at: The Annual Meeting of the Cardiovascular and Interventional Radiology Society of Europe. Antalya, Turkey, 20 September 2003.
65. Siewiorek GM, Wholey MH, Finol EA. In Vitro performance assessment of distal protection devices for carotid artery stenting. J. Endovascular Ther. 14, 712-724 (2007).
66. Mac Donald S. Brain injury secondary to carotid intervention. J. Endovasc. Ther. 14, 219-231 (2007).
67. Mac Donald S. Is there any evidence that cerebral protection is beneficial? Experimental data. J. Cardiovasc. Surg. 47, 127-136 (2006).
68. Sprouse LR, Peeters P, Bosiers MJ et al. The capture of visible debris by distal cerebral protection filters during carotid artery stenting: is it predictable? J. Vasc. Surg. 41, 950-955 (2005).
69. Angelini A, Reimers B, Dellabarbara M et al. Embolized debris during carotid artery stenting with cerebral protection device: a histopathologic survey. Presented at: AHA Meeting. Anaheim, CA, USA, 13 November 2001.
70. Cremonesi A, Manetti R, Liso A et al. Endovascular treatment of soft carotid plaques: a single center carotid stent experience. J. Endovasc. Ther. 13, 190-195 (2006).
71. Jaeger H, Mathias K, Drescher R et al. Clinical results of cerebral protection with a filter device during stent implantation of the carotid artery. Cardiovasc. Intervent. Radiol. 24, 249-256 (2001).
72. Barth A, Remonda L, Lovblad KO. Silent cerebral ischemia detected by diffusion-weighted MRI after carotid endarterectomy. Stroke 31, 1824-1828 (2000).
73. Tomczak R, Wunderlich A, Liewald F et al. Diffusion weighted MRI: detection of cerebral ischemia before and after carotid thromboendarterectomy. J. Comput. Assist. Tomogr. 25, 247-250 (2001).
74. Hammer FD, Lacroix V, Duprez T et al. Cerebral mico-embolization after protected carotid artery stenting in surgical high-risk patients: results of a 2-year prospective study. J. Vasc. Surg. 42, 847-853 (2005).
75. Vermeer SE, Prins ND, Den Heijer T et al. Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 348, 1215-1222 (2003).
76. Heyer EJ, Adamas DC, Somon RA. Neuropsychometric changes in patients after carotid endarterectomy. Stroke 29, 1110-1115 (1998).
77. Aronow HD, Shishehbor M, Davis DA et al. Leukocyte count predicts microembolic Doppler signals during carotid stenting: a link between inflammation and embolization. Stroke 36, 1910-1914 (2005).
78. Bosiers M, De Donato G, Deloose K et al. Does free cell area influence the outcome in carotid artery stenting? Eur. J. Endovasc. Surg. 33, 135-141 (2007).
79. Verzini F, Cao P, De Rango P et al. Appropriateness of leanrning curve for carotid artery stenting: an analysis of periprocedural complications. J. Vasc. Surg. 44, 1205-1211 (2006).
80. Henry M, Polydorou A, Henry I. New distal embolic protection device. The FiberNet 3-dimensional filter. First carotid human study. Catheter. Cardiovasc. Interv. 69, 1026-1036 (2007).
81. Roubin G: Carotid angioplasty and stenting. Presented at: TCT Meeting. Washington, DC, USA, 15-19 September 2003.
82. Mathias K: Carotid angioplasty and stenting. Presented at: TCT Meeting. Washington, DC, USA, 24-28 September 2002.
83. Iyer V, Dedonato G, Deloose K et al. The type of embolic protection does not influence the outcome in carotid artery stenting. J. Vasc. Surg. 46, 251-256 (2007).
84. Biasi GM, Sampaolo A, Mingazzini P. Computer analysis of ultrasonic plaque echolucency in identifying high risk carotid bifurcations lesions. Eur. J. Endovasc. Surg. 17, 476-479 (1999).
85. Biasi GM, Ferrari SA, Nicolaides AN. The ICAROS Registry of Carotid Artery Stenting. J. Endovasc. Ther. 8, 46-53 (2001).
86. Abu Rahma AF, Covelli MA, Robinson PA. The role of carotid duplex ultrasound in evaluating plaque morphology: potential use in selecting patients for carotid stenting. J. Endovasc. Surg. 6, 59-65 (1999).
87. Biasi GM, Froio A, Deleo G et al. Indication for carotid endarterectomy vs carotid stenting for the prevention of brain embolization from carotid artery plaques: in search of consensus. J. Endovasc. Surg. 13, 578-591 (2006).
88. Moussa I. Risk, stratification may improve carotid stenting in asymptomatic patients. J. Interv. Cardiol. 18, 385-388 (2005).
89. Spence JD, Tamoya A, Lownie SP et al. Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke 36, 2373-2378 (2005).
90. Bernick C, Kuller L, Dulberg C et al. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology 57, 1222-1229 (2001).
91. Silverstrini M, Vernieri F, Pasqualetti P et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 283, 2122-2127 (2000).
92. Schillinger M, Gschwendtner M, Reimers B et al. Does carotid stent cell design matter? Stroke 39, 905-909 (2008).
93. Lin PH, Zhou W, Kougias P et al. Assessing the learning curve of CAS. Endovasc. Today 5, 68-74 (2006).
94. Mas JL, Chatellier G, Beyssen B et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N. Engl. J. Med. 355, 1660-1671 (2006).